跳至主要内容
临床试验/CTRI/2018/06/014439
CTRI/2018/06/014439进行中(未招募)4 期

An Open Labeled, Placebo Controlled Trial to Evaluate Role of Probiotic- Bacillus subtilis HU58 and Bacillus coagulans SC208 on Antibiotic associated Diarrhoea in Humans

Synergia Life Sciences Pvt Ltd1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2018年6月18日最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
75
试验地点
1
主要终点
To evaluate the role of Probiotic- Bacillus subtilis HU58 and Bacillus coagulans SC208 in Antibiotic associated Diarrhoea in Humans in comparison to placebo

研究概览

简要总结

The current study is formulated in order to evaluate the effect of supplementation of Probiotic Bacillus subtilis HU58 and Bacillus coagulans SC209 on Antibiotic associated Diarrhea in humans in comparison with placebo.

N = 75

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Male and female aged 18 to
  • 2.Stable ECG.
  • 3.Willing to give informed consent.

排除标准

  • 1.Sero positive patients.
  • 2.Pregnancy.
  • 3.Subjects who are on other Probiotics or prebiotics.
  • 4.Subjects who are addicted to tobacco, alcohol.
  • 5.Subjects who are on any other medication than prescribed oral antibiotics.

结局指标

主要结局

To evaluate the role of Probiotic- Bacillus subtilis HU58 and Bacillus coagulans SC208 in Antibiotic associated Diarrhoea in Humans in comparison to placebo

时间窗: 15 days

次要结局

  • Safety and tolerability; clinical variables(15 days)

研究者

申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验